A weight-loss pill has been hailed as a potential ‘holy grail’ in the fight against obesity after a major study showed it did not increase the risk of serious heart problems.
Researchers say lorcaserin is the first weight-loss drug to be deemed safe for heart health with long-term use.
Taken twice a day the drug is an appetite suppressant which works by stimulating brain chemicals to induce a feeling of fullness.
A US study saw 12,000 people who were either obese or overweight given the pills or a placebo – with those who took the drug shedding an average of 4kg (9lbs) in 40 months.
Further analysis showed no big differences in tests for heart valve damage.
Tam Fry of Britain’s National Obesity Forum said the drug is potentially the ‘holy grail’ of weight-loss medicine.
‘I think it is the thing everybody has been looking for’ he said.